Kratom product study for regular users
This study watches how regular kratom users react to their own kratom product. It aims to learn more about kratom's effects in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older.
- You have used kratom more than 5 times a week for at least 3 months.
- You can speak and understand English.
- You are willing to give a sample of your kratom in its unopened, labeled package.
- You have not had a bad reaction to a normal dose of kratom in the last month or ever needed medical help for it.
- You only swallow your kratom (do not smoke or inject it).
- You do not have a substance problem with alcohol, sedatives, or opioids, and have not used fentanyl in the last month.
- You do not have a current or past psychotic disorder, or untreated severe depression or bipolar disorder.
- You are not pregnant or nursing, and have no other health issues that make the study risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a natural compound found in plants, called myrcene, affects the body's response to THC (the active ingredient in cannabis). It may help us understand how these substances work together.
This study tests how certain psychoactive substances affect your mind and body. It is looking for healthy volunteers to take part in supervised sessions to explore the effects of these drugs.
This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.
This early study tests how kratom can change the body’s handling of oxycodone (a prescription opioid) and how safe and measurable the effects are. It may help researchers understand drug interactions, especially for people who have used kratom and opioids before.
This trial studies medicines (clonidine and/or buprenorphine) to help manage kratom dependence and kratom withdrawal symptoms. You may be asked to regularly track withdrawal symptoms in diaries to help the study team monitor safety and response.
This study tests an investigational oral medication called MG001 in healthy people who have recently used oral opioids. It aims to see how the drug affects your body and whether it is safe.
Hear when a new Kratom Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.